Home Supplements How We Rate Blog
Nicotinamide / Vitamin B3 amide

Niacinamide

Research reviewed: Up until 03/2026

Niacinamide (Nicotinamide / Vitamin B3 amide) is a dietary supplement with 8 published peer-reviewed studies involving 1,930 participants, researched for Skin Health, Acne Reduction, Glucose Metabolism and 1 more areas.

8
Studies
1,930
Participants
1995–2021
Research Span

Evidence at a Glance

Strength is scored by study design, sample size, study type, and outcomes

Overall: Very Strong Evidence

Skin Health

Strong
2 studies 2 of 2 positive 67 participants

Acne Reduction

Moderate
2 studies 1 of 2 positive 152 participants

Glucose Metabolism

Moderate
2 studies 1 of 2 positive 80 participants

Neuroprotection

Moderate
2 studies 0 of 2 positive 30 participants 1 human

Research Visualised

Visual breakdown of the clinical data.

Study Quality Breakdown

What types of studies were conducted

6/8
Randomised
4/8
Double-Blind
3/8
Placebo-Controlled

Participants Per Study

Larger samples = more reliable results

Study 1 (2002)
40
Study 2 (2011)
27
Study 1 (2014)
76
Study 2 (1995)
76
Study 1 (2000)
80
Study 2 (2006)
0
Study 1 (2021)
27
Study 2 (2008)
3

Research Timeline

When the studies were published

1
1995
1
2000
1
2002
1
2006
1
2008
1
2011
1
2014
1
2021

All Studies

Detailed breakdown of each trial. Click to expand.

Skin Health

1

To assess the efficacy of niacinamide on hyperpigmentation and overall skin appearance.

2002 40 participants 8 weeks 5% topical niacinamide
Human Study RCT Double-Blind Placebo Positive

Study Type

Randomised, double-blind, placebo-controlled

Purpose

To assess the efficacy of niacinamide on hyperpigmentation and overall skin appearance.

Dose

5% topical niacinamide

Participants

40 Asian women with facial hyperpigmentation

Duration

8 weeks

Results

Topical niacinamide significantly reduced hyperpigmentation and improved overall skin tone. Melanin transfer from melanocytes to keratinocytes was inhibited.

How They Measured It

Chromameter measurements, dermatologist assessments of skin evenness and tone

Read full study
2

To compare niacinamide cream to hydroquinone cream for skin lightening.

2011 27 participants 8 weeks 4% niacinamide cream vs 4% hydroquinone cream
Human Study RCT Double-Blind Positive

Study Type

Randomised, double-blind, active-controlled

Purpose

To compare niacinamide cream to hydroquinone cream for skin lightening.

Dose

4% niacinamide cream vs 4% hydroquinone cream

Participants

27 women with facial hyperpigmentation

Duration

8 weeks

Results

Both niacinamide and hydroquinone significantly reduced hyperpigmentation. Niacinamide was better tolerated with fewer side effects, making it a suitable alternative for skin brightening.

How They Measured It

Mexameter (melanin index), clinical photography, subject assessment

Read full study

Acne Reduction

1

To evaluate oral niacinamide supplementation for inflammatory acne vulgaris.

2014 76 participants 8 weeks 750 mg/day oral niacinamide
Human Study RCT Double-Blind Placebo Positive

Study Type

Randomised, double-blind, placebo-controlled

Purpose

To evaluate oral niacinamide supplementation for inflammatory acne vulgaris.

Dose

750 mg/day oral niacinamide

Participants

76 adults with moderate acne vulgaris

Duration

8 weeks

Results

Oral niacinamide significantly reduced inflammatory acne lesion counts compared to placebo. Anti-inflammatory properties were considered the primary mechanism.

How They Measured It

Lesion counts (inflammatory and non-inflammatory), IGA scale

Read full study
2

To compare topical niacinamide gel with clindamycin gel for acne vulgaris.

1995 76 participants 8 weeks 4% topical niacinamide
Human Study RCT Mixed

Study Type

Randomised, controlled trial

Purpose

To compare topical niacinamide gel with clindamycin gel for acne vulgaris.

Dose

4% topical niacinamide

Participants

76 patients with acne vulgaris

Duration

8 weeks

Results

4% niacinamide gel was as effective as 1% clindamycin gel in reducing acne lesion counts. As niacinamide carries no risk of antibiotic resistance, it represents a valuable alternative.

How They Measured It

Acne lesion counts, Global Acne Assessment Score

Read full study

Glucose Metabolism

1

To evaluate niacinamide for beta-cell preservation in newly diagnosed type 1 diabetes.

2000 80 participants 12 months 25 mg/kg/day niacinamide
Human Study RCT Double-Blind Placebo Positive

Study Type

Randomised, double-blind, placebo-controlled

Purpose

To evaluate niacinamide for beta-cell preservation in newly diagnosed type 1 diabetes.

Dose

25 mg/kg/day niacinamide

Participants

80 children and adolescents with new-onset type 1 diabetes

Duration

12 months

Results

Niacinamide significantly preserved C-peptide levels (indicator of endogenous insulin production) compared to placebo. Insulin dose requirements were lower in the niacinamide group at 12 months.

How They Measured It

C-peptide levels, insulin dose requirements, HbA1c

Read full study
2

To review the evidence for niacinamide in prevention and treatment of type 1 diabetes.

2006 ? participants Various Various (typically 1-3 g/day)
Human Study Mixed

Study Type

Systematic review

Purpose

To review the evidence for niacinamide in prevention and treatment of type 1 diabetes.

Dose

Various (typically 1-3 g/day)

Participants

Multiple trials reviewed

Duration

Various

Results

Niacinamide has demonstrated beta-cell protective effects via PARP inhibition and anti-inflammatory mechanisms. Evidence for prevention of type 1 diabetes in high-risk individuals is suggestive but larger trials are needed.

How They Measured It

Review of clinical trials and mechanistic data

Read full study

Neuroprotection

1

To assess niacinamide supplementation for cognitive outcomes in Alzheimer's disease.

2021 27 participants 24 weeks 1,500 mg/day niacinamide
Human Study RCT Mixed

Study Type

Randomised, controlled pilot trial

Purpose

To assess niacinamide supplementation for cognitive outcomes in Alzheimer's disease.

Dose

1,500 mg/day niacinamide

Participants

27 patients with mild-moderate Alzheimer's disease

Duration

24 weeks

Results

Preliminary data suggested stabilisation of cognitive scores with niacinamide. The supplement was well tolerated. Larger confirmatory trials are warranted.

How They Measured It

MMSE, Alzheimer's Disease Assessment Scale - Cognitive (ADAS-Cog)

Read full study
2

To investigate niacinamide on tau pathology and neurodegeneration in an Alzheimer's model.

2008 3 participants 4 months 200 mg/kg niacinamide
Animal Study Mixed

Study Type

Animal study

Purpose

To investigate niacinamide on tau pathology and neurodegeneration in an Alzheimer's model.

Dose

200 mg/kg niacinamide

Participants

3xTg-AD transgenic mice

Duration

4 months

Results

Niacinamide treatment restored cognitive deficits in Alzheimer's model mice, reduced phosphorylated tau levels, and improved spatial learning. Results support niacinamide as a candidate neuroprotective agent.

How They Measured It

Tau phosphorylation markers, spatial memory (Morris water maze), histology

Read full study

Frequently Asked Questions

Common questions about Niacinamide research

What does the research say about Niacinamide?

There are currently 10 peer-reviewed studies on Niacinamide (Nicotinamide / Vitamin B3 amide), involving 1,930 total participants. Research covers Skin health, Acne reduction, Glucose metabolism and 1 more areas. The overall evidence strength is rated as Very Strong.

How strong is the evidence for Niacinamide?

The evidence is currently rated as "Very Strong Evidence". This rating is based on study design quality (randomisation, blinding, placebo controls), sample sizes, study types (7 human studies, 1 animal study), and reported outcomes.

What health goals has Niacinamide been studied for?

Niacinamide has been researched for: Skin health, Acne reduction, Glucose metabolism, Neuroprotection. Each area has its own body of evidence which you can explore in the study breakdowns above.

Are the studies on Niacinamide based on human trials?

Yes, 7 out of 10 studies are human trials. The remaining 1 is an animal study. Human trials carry more weight in our evidence scoring system.